Podcast Episodes
Back to Search
How Psychedelic Companies Attract Analyst Interest and Secure Coverage
With the US Election, there has been a renewed interest in psychedelic stocks, driven by RFK Jr.’s recent comments on psychedelic research and his st…
1 year, 7 months ago
Psychedelic Lobbyist, Top Gun Fighter Pilot Predict Industry Trends 2025
Happy Friday, everyone! Melissa Lavasani, CEO of Psychedelic Medicine, the leading psychedelics lobbyist firm, along with former Top Gun Fighter Pilo…
1 year, 7 months ago
HHS Declines Invitation to ALJ Hearing for Rescheduling Cannabis
On our latest Trade To Black podcast, Shadd and Anthony discuss why the U.S. Department of Health and Human Services (HHS) rejected a request from th…
1 year, 7 months ago
2025 Industry Expectations For The Farm Bill
On our latest Trade To Black podcast, hosts Shadd Dales and Anthony Varrell are joined by Michael Bronstein from ATACH. We will be covering the stat…
1 year, 7 months ago
CA Skip navigation Search Avatar image 0:41 / 15:28 Psychedelic Stock: Cybin Unveils Unprecedented 12-Month Results
Cybin (NYSE:CYBN) CEO Doug Drysdale, discusses the company’s groundbreaking results announced on Monday, November 18th. The key talking points inclu…
1 year, 7 months ago
Matt Gaetz Is Out & Pam Bondi Is In - What does this mean for the Cannabis Sector?
On our latest Trade To Black podcast, hosts Shadd Dales and Anthony Varrell break down some of the pressing headlines from this week. In the last fe…
1 year, 7 months ago
CEO Panel Analyzes Canadian Cannabis Future
We talk Canada featuring a panel of Canadian executives sharing their insights on the future of the Canadian cannabis landscape. Emma Andrews, CEO of…
1 year, 7 months ago
States Act Revival: Congresswoman Nancy Mace Leads Cannabis Reform Change
On our latest Trade To Black podcast, South Carolina Congresswoman Nancy Mace joins us to discuss cannabis reform and why she feels confident that pr…
1 year, 7 months ago
Gaetz's Appointment Looms: GOP Divided Over AG Role
Cybin (NYSE:CYBN) CEO Doug Drysdale will join us to discuss their latest trials, where they reported a 71% remission rate in patients with major depr…
1 year, 7 months ago
Small Cap Sunday: Psychedelic Stocks
With the US Election, there has been a renewed interest in Psychedelic Stocks. This episode is going to be a special Small Cap Sunday Show. We will e…
1 year, 7 months ago